Belantamab

Tax included
Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin.
MedChemExpress 
HY-P9980

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor; ADC Antibody
Application
Cancer-programmed cell death
CAS
2061894-48-0